Since in this current study GPR89A gene knockout has also resulted in reduced cell proliferation, migration and colony formation, it might be used as a new therapeutic target in combination with chemotherapy to overcome cisplatin resistance in NSCLC cells. This evidence concerns the gene GPHRA and non-small cell lung carcinoma.